BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33169870)

  • 1. Synthesis of novel cyanine dyes as antitumor agents.
    Fadda AA; Tawfik EH; Abdel-Motaal M; Selim YA
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000186. PubMed ID: 33169870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some novel dimethine, bis-dimethine cyanine dyes and octacosamethine cyanine dyes endowed with promising biological potency against (HepG2), (Hela), (MCF-7), (MIA), (SN12C) and (H358) cell lines.
    El-Mekawy RE; Fadda AA
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1747-1752. PubMed ID: 29673982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-aggregation NIR-II heptamethine-cyanine dye with a stereo-specific cyanine for imaging-guided photothermal therapy.
    Qian H; Cheng Q; Tian Y; Dang H; Teng C; Yan L
    J Mater Chem B; 2021 Mar; 9(11):2688-2696. PubMed ID: 33667292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.
    Zhao X; Yang Y; Yu Y; Guo S; Wang W; Zhu S
    Chem Commun (Camb); 2019 Nov; 55(90):13542-13545. PubMed ID: 31647067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2617-2621. PubMed ID: 31378572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near infrared active heptacyanine dyes with unique cancer-imaging and cytotoxic properties.
    Henary M; Pannu V; Owens EA; Aneja R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1242-6. PubMed ID: 22177785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
    Hafez HN; El-Gazzar ABA
    Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, optical properties and cytotoxicity of meso-heteroatom substituted IR-786 analogs.
    Ma X; Laramie M; Henary M
    Bioorg Med Chem Lett; 2018 Feb; 28(3):509-514. PubMed ID: 29249562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.
    Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA
    Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of trimethine cyanine dyes as fluorescent probes for the detection of tau fibrils in Alzheimer's disease brain and olfactory epithelium.
    Gu J; Anumala UR; Heyny-von Haußen R; Hölzer J; Goetschy-Meyer V; Mall G; Hilger I; Czech C; Schmidt B
    ChemMedChem; 2013 Jun; 8(6):891-7. PubMed ID: 23592568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents.
    Hu K; Qi YJ; Zhao J; Jiang HF; Chen X; Ren J
    Eur J Med Chem; 2013 Jun; 64():529-39. PubMed ID: 23685571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
    Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
    Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antitumor, cytotoxic and antioxidant evaluation of some new pyrazolotriazines attached to antipyrine moiety.
    Metwally MA; Gouda MA; Harmal AN; Khalil AM
    Eur J Med Chem; 2012 Oct; 56():254-62. PubMed ID: 23022735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.